These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18828013)
21. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin. van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105 [TBL] [Abstract][Full Text] [Related]
22. 5-HT2A receptor density is decreased in the at-risk mental state. Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021 [TBL] [Abstract][Full Text] [Related]
24. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399 [TBL] [Abstract][Full Text] [Related]
25. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm. van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702 [TBL] [Abstract][Full Text] [Related]
26. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling. Riss PJ; Hong YT; Williamson D; Caprioli D; Sitnikov S; Ferrari V; Sawiak SJ; Baron JC; Dalley JW; Fryer TD; Aigbirhio FI J Cereb Blood Flow Metab; 2011 Dec; 31(12):2334-42. PubMed ID: 21750562 [TBL] [Abstract][Full Text] [Related]
27. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. Uchida H; Chow TW; Mamo DC; Kapur S; Mulsant BH; Houle S; Pollock BG; Graff-Guerrero A Int J Geriatr Psychiatry; 2011 Dec; 26(12):1300-8. PubMed ID: 21351153 [TBL] [Abstract][Full Text] [Related]
28. Measurement of changes in endogenous serotonin level by positron emission tomography with [ Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154 [TBL] [Abstract][Full Text] [Related]
29. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons. Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008 [TBL] [Abstract][Full Text] [Related]
31. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging. Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929 [TBL] [Abstract][Full Text] [Related]
32. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain. Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452 [TBL] [Abstract][Full Text] [Related]